New Peanut Allergy Drug Shows Unprecedented Success

Share this post

Two-thirds of children and adolescents could tolerate two peanuts after a year of immunotherapy, results from the phase 3 PALISADE study show, which could protect them from accidental ingestion.
Medscape Medical News

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.


Share this post

Be the first to comment

Leave a Reply